Study unveils ‘plug-and-play’ CAR T technology designed to adapt as cancer changes

City of Hope develops adaptable CAR T technology that can be updated after treatment to keep pace with evolving tumors. “Much like a software update adds new features to a smartphone after you buy it, meditope allows us to send new instructions to CAR T cells already in the body,” said Dr. John Williams, a City of Hope professor.